Cardiac resynchronization therapy in heart failure patients with less severe left ventricular dysfunction
Ofek Y Hai1, Robert J Mentz, Faiez Zannad
1Division of Cardiovascular Medicine, Department of Medicine, State University of New York (SUNY) Downstate Medical Center, Brooklyn, NY, USA.
European Journal of Heart Failure
|December 4, 2014
Summary
Cardiac resynchronization therapy (CRT) may benefit heart failure patients with LVEF >35%. This therapy shows potential for improving cardiac remodelling, reducing mortality, and decreasing heart failure hospitalizations in this group.
Area of Science:
- Cardiology
- Heart Failure Management
- Cardiac Electrophysiology
Background:
- Cardiac resynchronization therapy (CRT) is established for heart failure patients with LVEF ≤35% and electrical dyssynchrony.
- Limited data exists on CRT's efficacy in patients with less severe left ventricular (LV) dysfunction (LVEF >35%).
Purpose of the Study:
- To review the current literature on the potential benefits of CRT in heart failure patients with LVEF >35%.
Main Methods:
- Review of post-hoc analyses from landmark CRT trials.
- Synthesis of available literature on CRT in patients with milder LV dysfunction.
Main Results:
- Post-hoc analyses suggest CRT may benefit patients with LVEF >35%.
- Observed improvements include cardiac reverse remodelling, reduced all-cause mortality, and fewer heart failure hospitalizations.
Conclusions:
- CRT may offer significant benefits for heart failure patients with LVEF >35%.
- Further research is warranted to fully establish CRT's role in this patient population.
Related Concept Videos
01:22Heart Failure VI: Adjunct Therapies
614
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
614
01:30Cardiomyopathy II: Dilated Cardiomyopathy
811
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
811
01:29Cardiomyopathy V: Interprofessional Care
724
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
724
01:26Heart Failure Drugs: Inotropic Agents
2.0K
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
2.0K
01:30Heart Failure IV: Classification and Diagnostic Evaluation
649
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
649
01:30Heart Failure V: Medical Management
594
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
594